Keyphrases
Type 2 Diabetes Mellitus (T2DM)
74%
Endogenous Glucose Production
63%
Anti-inflammatory Effect
63%
Insulin Sensitizers
63%
Thiazolidinediones
63%
Pioglitazone
47%
Obese Subjects
47%
Rodents
45%
KATP Channel
45%
Diazoxide
43%
Macrophages
39%
Glucose Production
31%
Macrophage Content
31%
Central Regulation
31%
Plasminogen Activator inhibitor-1 (PAI-1)
31%
Obese Patients
31%
Fatty Acids
31%
Older Adults
31%
Middle-aged
31%
Glucose Effectiveness
31%
Non-obese
31%
Induced Production
31%
Acid Activation
31%
Adult Participants
31%
Hyperglycemia
30%
Insulin Resistance
29%
Pancreatic Clamp
25%
Clamp Study
21%
Placebo
20%
Adipose Tissue Biopsy
20%
Free Fatty Acids
18%
Fatty Acid Composition
18%
Type 2 Diabetic Patients
15%
Adipose Tissue Inflammation
15%
Glucose Infusion Rate
15%
Drug Choice
15%
Subcutaneous Adipose Tissue
15%
Uncoupling Protein 1 (UCP1)
15%
Fat Browning
15%
Inflammatory Parameters
15%
Coactivator
15%
Type 2 Diabetic
13%
Adipose Tissue Macrophages
13%
Infiltration
12%
Randomized Placebo-controlled Trial
12%
Plasminogen Activator inhibitor-1 Gene
10%
Fibro-adipogenic Progenitors
10%
Glyburide
10%
Glycemic Control
9%
Diabetic Subjects
9%
Biochemistry, Genetics and Molecular Biology
Skeletal Muscle
100%
Thiazolidinedione
95%
Pioglitazone
84%
Macrophage
79%
Antiinflammatory Activity
66%
Insulin Resistance
60%
Insulin Sensitivity
55%
Tumor Necrosis Factor
47%
Adipose Tissue Macrophages
43%
Gluconeogenesis
42%
Glucose Metabolism
35%
Resveratrol
31%
Plasminogen Activator Inhibitor-1
31%
Mouse
31%
Vitamin D
31%
Adipocyte
31%
Eicosanoid Receptor
31%
Peroxisome Proliferator-Activated Receptor Gamma
21%
Uncoupling Protein
21%
Lifespan
20%
Human Aging
19%
Diazoxide
19%
Interleukin-6
18%
Insulin Release
15%
Peroxisome Proliferator-Activated Receptor
15%
DNA Repair
15%
Sterol Regulatory Element-Binding Protein
15%
Phenotype
15%
Observational Study
15%
Metabolic Pathway
15%
MicroRNA
15%
Free Fatty Acids
15%
Protein Metabolism
15%
Pleiotropy
15%
Clinical Trial
15%
Stem Cell Self-Renewal
15%
ATP-Sensitive Potassium Channel
15%
Transcriptomics
15%
Beta Oxidation
15%
Dendritic Cell
15%
CD68
15%
Transcriptome
15%
Neutrophil Granulocyte
15%
Angiogenesis
15%
Gene Expression Profiling
15%
Gene Expression
13%
Secretion (Process)
12%
Synapsin I
10%
Nitric Oxide Synthase
10%
Animal Model
9%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
63%
Thiazolidinedione
63%
Antiinflammatory Activity
63%
Adipose Tissue
63%
Pioglitazone
47%
Macrophage
39%
Gluconeogenesis
39%
Receptor Study
31%
Fatty Acid
31%
Myofibrosis
31%
Chronic Kidney Disease
31%
Patient with Type 2 Diabetes
31%
Middle Age
31%
Plasminogen Activator Inhibitor-1
31%
Xylitol
31%
Placebo
31%
Insulin Resistance
27%
Diazoxide
19%
Adenosine Triphosphate Sensitive Potassium Channel
15%
Drug Choice
15%
Peroxisome Proliferator Activated Receptor Gamma
15%
Inducible Nitric Oxide Synthase
15%
Uncoupling Protein 1
15%
Biopsy
15%
Diabetes
11%
Neutrophil
7%
Dendritic Cell
7%
Infusion Rate
7%
Disease
7%
Adverse Event
7%
Interleukin-6
7%
Drug Therapy
7%
Skeletal Muscle
7%
Body Mass Index
7%
Renal Replacement Therapy
7%
Hyperglycemia
7%
Glucose Infusion
7%